A phase II study to determine the efficacy and safety of lipoplatin and gemcitabine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
Latest Information Update: 04 Jan 2017
At a glance
- Drugs Cisplatin (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2017 New trial record